Pneumocystis carinii: taxing taxonomy.

European Journal of Epidemiology
W Hughes

Abstract

The detailed taxonomy of Pneumocystis carinii has not been decided. Most experts agree that it is either a fungus or a protozoan. In favor of a fungal designation are the recent reports that 16s and 18s rRNA sequences of P. carinii have greater homology to Saccharomyces cerevisiae and Neurospora crassa than to selected protozoa. Other studies show that sequences of the 18s and 26s rRNA, microtubular ultrastructure, membrane fusion potential and DNA content per cell resemble protozoa more than fungi. Therapeutic responsiveness to drugs effective against protozoa, namely pentamidine (Trypanosoma, Leishmania, sp), trimethoprim-sulfamethoxazole (Isospora sp), pyrimethamine-sulfadiazine (Toxoplasma, Plasmodium sp) and nonresponsiveness to antifungal drugs such as amphotericin B and ketoconazole indicate characteristics similar to protozoa. Taxonomic placement is based upon multifactional determinants, not a single attribute. Data are not yet available to make such a determination for P. carinii. Furthermore, detailed rules on qualifying criteria for both protozoan and fungal classifications are lacking, especially in the utilization of methods in molecular genetics for this purpose.

References

Jun 10, 1976·Zeitschrift Für Parasitenkunde·M E VossenA M Stadhouders
Jan 1, 1988·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·M S GradusM Lerner
Aug 1, 1970·The Journal of protozoology·J Vavra, K Kucera
Feb 1, 1982·Experimental Parasitology·K YonedaM G Birk

❮ Previous
Next ❯

Citations

May 1, 1992·European Journal of Epidemiology·E Dei-CasD Camus
Mar 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J W Smith
Jan 1, 1991·International Journal of Antimicrobial Agents·I Varthalitis, F Meunier
Apr 3, 2003·Cancer Treatment Reviews·Beela S Mathew, Stuart A Grossman
Feb 18, 2009·European Journal of Public Health·María M Morales-Suárez VarelaJorn Olsen
Aug 1, 1993·Molecular Microbiology·G P Belfield, M F Tuite
Sep 23, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M H NielsenE Dei-Cas
Jan 31, 2006·The Journal of Eukaryotic Microbiology·Scott A RedheadJames R Stringer
Feb 5, 2000·The Journal of Hospital Infection·A G Duse
Oct 1, 1993·Cancer Treatment Reviews·I Varthalitis, F Meunier
May 4, 2004·Trends in Microbiology·Melanie T Cushion
Nov 28, 2002·International Journal of Medical Microbiology : IJMM·James R Stringer
Dec 1, 2010·FEMS Yeast Research·Magali ChabéEduardo Dei-Cas
Nov 4, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N RespaldizaE J Calderon
May 1, 1992·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·M P GoheenJ W Smith
Mar 14, 2017·Future Microbiology·Wolfram WindischOliver Schildgen
Oct 1, 1992·Infection and Immunity·M F Ypma-WongP S Sypherd
Apr 1, 1991·Clinical Microbiology Reviews·M S Bartlett, J W Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.